Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
IGM Biosciences, Inc. (IGMS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Thompson Elizabeth H.Z. (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 31,000 options to buy @ $6.71, valued at $208k
10/05/2023 3 Thompson Elizabeth H.Z. (Director) has filed a Form 3 on IGM Biosciences, Inc.
10/03/2023 4 Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 492 shares @ $0
10/03/2023 4 Lee Michael Stewart (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 492 shares @ $0
10/03/2023 4 Gauthier George (Chief Commercial Officer) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Sold 935 shares @ $7.9463, valued at $7.4k
10/03/2023 4 Topsoe Jakob Haldor (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 492 shares @ $0
10/03/2023 4 Topsoe Christina Teng (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 738 shares @ $0
10/03/2023 4 LOBERG MICHAEL D (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 1,138 shares @ $0
10/03/2023 4 BEHRENS M KATHLEEN (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 800 shares @ $0
10/03/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 554 shares @ $0
10/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors"
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 8-K Quarterly results
Docs: "IGM Biosciences Announces Second Quarter 2023 Financial Results – Continued progress in clinical development across portfolio – – Public equity offering and concurrent private placement with gross proceeds of $120.0 million – MOUNTAIN VIEW, Calif., August 3, 2023"
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/19/2023 SC 13D/A Topsoe Holding A/S reports a 32.2% stake in IGM Biosciences, Inc.
07/07/2023 D Form D - Notice of Exempt Offering of Securities:
07/05/2023 4 LOBERG MICHAEL D (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 1,138 shares @ $0
07/05/2023 4 Gauthier George (Chief Commercial Officer) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Sold 936 shares @ $9.4209, valued at $8.8k
07/05/2023 4 Topsoe Christina Teng (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 3,000 shares @ $9.3189, valued at $28k
Granted 738 shares @ $0
07/05/2023 4 BEHRENS M KATHLEEN (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 800 shares @ $0
07/05/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 554 shares @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Sold 80,423 shares @ $9.42, valued at $757.6k
Bought 80,423 shares @ $9.42, valued at $757.6k
Disposed of 54,740 shares @ $9.42, valued at $515.7k
Acquired 54,740 shares @ $9.42, valued at $515.7k
Granted 492 shares @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2023 4 Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 2,812,500 options to buy @ $8, valued at $22.5M
06/28/2023 4 Topsoe Jakob Haldor (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 1,687,500 options to buy @ $8, valued at $13.5M
06/28/2023 4 Topsoe Christina Teng (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 1,687,500 options to buy @ $8, valued at $13.5M
06/28/2023 4 Topsoe Holding A/S (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 1,687,500 options to buy @ $8, valued at $13.5M
06/28/2023 4 BEHRENS M KATHLEEN (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 112,500 shares @ $8, valued at $900k
06/28/2023 SC 13D/A Redmile Group, LLC reports a 9.9% stake in IGM Biosciences, Inc.
06/28/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 10% stake in IGM Biosciences, Inc.
06/28/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Bought 413,175 options to buy @ $8, valued at $3.3M
Bought 5,211,825 options to buy @ $8, valued at $41.7M
05/25/2023 4 Takimoto Chris H (Chief Medical Officer) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 962 shares @ $11.71, valued at $11.3k
Sold 1,244 shares @ $12.3005, valued at $15.3k
Sold 15 shares @ $13.005, valued at $195.1
05/25/2023 4 Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.
Txns: Granted 398 shares @ $11.71, valued at $4.7k
Sold 1,244 shares @ $12.3005, valued at $15.3k
Sold 15 shares @ $13.005, valued at $195.1
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy